Metabolic Effects of the Incretin Mimetic Exenatide in the Treatment of Type 2 Diabetes

Por Schnabel, Catherine A, Wintle, Matthew, Kolterman, Orville
Publicado em 2006

Trimeric Association of Hox and TALE Homeodomain Proteins Mediates Hoxb2 Hindbrain Enhancer Activity

Por Jacobs, Yakop, Schnabel, Catherine A., Cleary, Michael L.
Publicado em 1999

Performance and Clinical Evaluation of the 92-Gene Real-Time PCR Assay for Tumor Classification

Por Erlander, Mark G., Ma, Xiao-Jun, Kesty, Nicole C., Bao, Lei, Salunga, Ranelle, Schnabel, Catherine A.
Publicado em 2011

Risk stratification with Breast Cancer Index for late distant recurrence in patients with clinically low-risk (T1N0) estrogen receptor-positive breast cancer

Por Schroeder, Brock, Zhang, Yi, Stål, Olle, Fornander, Tommy, Brufsky, Adam, Sgroi, Dennis C., Schnabel, Catherine A.
Publicado no NPJ Breast Cancer (2017)

CREB Binding Protein Interacts with Nucleoporin-Specific FG Repeats That Activate Transcription and Mediate NUP98-HOXA9 Oncogenicity

Por Kasper, Lawryn H., Brindle, Paul K., Schnabel, Catherine A., Pritchard, Colin E. J., Cleary, Michael L., van Deursen, Jan M. A.
Publicado em 1999

Molecular classification of cancer with the 92-gene assay in cytology and limited tissue samples

Por Brachtel, Elena F., Operaña, Theresa N., Sullivan, Peggy S., Kerr, Sarah E., Cherkis, Karen A., Schroeder, Brock E., Dry, Sarah M., Schnabel, Catherine A.
Publicado no Oncotarget (2016)

Performance and prognostic utility of the 92-gene assay in the molecular subclassification of ampullary adenocarcinoma

Por Overman, Michael J., Soifer, Harris S., Schueneman, Aaron Joel, Ensor, Joe, Adsay, Volkan, Saka, Burcu, Neishaboori, Nastaran, Wolff, Robert A., Wang, Huamin, Schnabel, Catherine A., Varadhachary, Gauri
Publicado no BMC Cancer (2016)

Prediction of late distant recurrence in estrogen receptor positive breast cancer patients: prospective comparison of the Breast Cancer Index (BCI), Oncotype DX recurrence score, a...

Por Sgroi, Dennis C., Sestak, Ivana, Cuzick, Jack, Zhang, Yi, Schnabel, Catherine A., Schroeder, Brock, Erlander, Mark G., Dunbier, Anita, Sidhu, Kally, Lopez-Knowles, Elena, Goss, Paul E., Dowsett, Mitch
Publicado em 2013

Development and validation of a 32-gene prognostic index for prostate cancer progression

Por Wu, Chin-Lee, Schroeder, Brock E., Ma, Xiao-Jun, Cutie, Christopher J., Wu, Shulin, Salunga, Ranelle, Zhang, Yi, Kattan, Michael W., Schnabel, Catherine A., Erlander, Mark G., McDougal, W. Scott
Publicado em 2013

Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study

Por Sgroi, Dennis C., Chapman, Judy-Anne W., Badovinac-Crnjevic, T., Zarella, Elizabeth, Binns, Shemeica, Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Pritchard, Kathleen I., Han, Lei, Shepherd, Lois E., Goss, Paul E., Pollak, Michael
Publicado no Breast Cancer Res (2016)

Prediction of Late Disease Recurrence and Extended Adjuvant Letrozole Benefit by the HOXB13/IL17BR Biomarker

Por Sgroi, Dennis C., Carney, Erin, Zarrella, Elizabeth, Steffel, Lauren, Binns, Shemeica N., Finkelstein, Dianne M., Szymonifka, Jackie, Bhan, Atul K., Shepherd, Lois E., Zhang, Yi, Schnabel, Catherine A., Erlander, Mark G., Ingle, James N., Porter, Peggy, Muss, Hyman B., Pritchard, Katherine I., Tu, Dongsheng, Rimm, David L., Goss, Paul E.
Publicado em 2013